GSE158834 7 V 3 PALMITIC ACID HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE158834 7 V 3 PALMITIC ACID HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE158834 7 V 3 PALMITIC ACID HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE158834 7 V 3 PALMITIC ACID HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE158834 7 V 3 PALMITIC ACID HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

carbonic anhydrase 2

Gene

secretory leukocyte peptidase inhibitor

Gene

cell division cycle 20

Gene

paternally expressed 10

Gene

interferon induced protein with tetratricopeptide repeats 1

Gene

aldo-keto reductase family 1 member B10

Gene

CD9 molecule

Gene

heat shock protein family A (Hsp70) member 1A

Gene

gap junction protein alpha 1

Gene

insulin like growth factor binding protein 2

  • Gene

    carbonic anhydrase 2


  • Gene

    secretory leukocyte peptidase inhibitor


  • Gene

    cell division cycle 20


  • Gene

    paternally expressed 10


  • Gene

    interferon induced protein with tetratricopeptide repeats 1


  • Gene

    aldo-keto reductase family 1 member B10



  • Gene

    heat shock protein family A (Hsp70) member 1A


  • Gene

    gap junction protein alpha 1


  • Gene

    insulin like growth factor binding protein 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.